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Rating
￿Of importance.
Introduction
Effective hypertension management is still a clinical
challenge. The prevalence of hypertension continues to
rise in the western world, despite awareness of its serious
cardiovascular consequences [1]. Adequate blood pressure
(BP) control is of clear public health importance, but
recent reports indicate that as many as two thirds of those
being treated for hypertension in the United States do
not have BP under proper control [2]. To address this
important public health issue, a large study evaluating the
efficacy of a nonconventional, two-level (patient and
physician) management strategy for hypertension man-
agement was timely.
Aims
Using a large, prospective, and randomized community-
based trial, the Hypertension Improvement Project (HIP)
recently reported their findings on the comparative effec-
tiveness of 1) physician intervention, 2) patient interven-
tion, or 3) the combination of such interventions [3].
Methods
Published in the journal Hypertension in November 2009,
the HIP study demonstrated differences in BP-lowering
effects between patient intervention, physician intervention,
and combined interventions. The patient-intervention strategy
consisted of 20 weekly group sessions over 6 months,
conducted by experienced behavioral personnel. The focus
of the intervention was the use of motivational interviewing
techniques to assist patients toward weight loss if overweight,
to increase awareness of dietary approaches to controlling BP
(with the Dietary Approaches to Stop Hypertension [DASH]
dietary pattern [4]), to increase moderate-to-vigorous physical
activity, and to reduce sodium intake and moderate alcohol
intake. Additionally, the patient intervention aimed to
encourage adherence to the antihypertensive medication
regimen. In short, this patient-intervention regimen was
designed to “promote frequent self-monitoring, feedback,
goal setting, and social support and used motivational
interviewing techniques” [3].
The physician intervention strategy consisted of two
training modules for the clinicians: one addressed the
Seventh Joint National Committee on Prevention, Detec-
tion, Evaluation and Treatment of High Blood Pressure
(JNC-7) guidelines [5], and the second addressed lifestyle
modification for BP control. Additionally, each physician in
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summarized the major JNC-7 guidelines, including lifestyle
guidelines and a decision tree. Results of a quality
improvement procedure assessing clinical performance
measures and quarterly feedback on adherence to JNC-7
guidelines were provided to the physician intervention
group. The goal of the physician-intervention regimen was
to increase physicians’ awareness of current recommenda-
tions for hypertension treatment goals and management.
The HIP study then evaluated the effectiveness between
groups exposed to patient intervention alone, physician
intervention alone, or both interventions combined, as com-
pared with no intervention (usual care). To assess both short-
term and long-term BP consequences of these interventions,
the HIP study reported systolic BP (SBP) and diastolic BP
(DBP) changes at 6 and 18 months postrandomization.
Results
At 6 months, the patient-intervention group showed a
significant decrease in SBP of 7.1±12.1 mm Hg (mean ±
SD; P<0.05), with a net reduction (main effect adjusted for
baseline pressure) of 2.6 mm Hg (95% CI, −4.4 to −0.7; P=
0.01). The significant reduction of BP at 6 months in the
patient-intervention group is perhaps not surprising, as
patients are their best advocate for health and well-being.
The support group and lifestyle-based interventions provid-
ed may have directly increased patients’ motivation to
lower their BP via tools taught to them such as better
adherence to lifestyle modifications (healthier diet and
increased physical activity), and through increased compli-
ance with pharmacologic treatments. Additionally, patients
who become more aware of their hypertension status are
more likely to proactively communicate their BP concerns
with their physicians, which in turn may help their
physicians to make timely treatment recommendations.
On the other hand, patients in the group with the
physician intervention only did not show a statistically
significant drop in BP at the 6-month point; they had a
mean decrease in SBP of 5.3±12.1 mm Hg (P>0.05), but a
net reduction (main effect adjusted for baseline pressure) of
only 0.3 mm Hg (95% CI, −1.5–2.2; P=0.76).
Svetkey et al. [3] demonstrated that the most effective
outcome was seen in the group that received both patient
and physician interventions. In this combined-intervention
group, the SBP main effect (adjusted for baseline pressure)
fell the most, at 9.7±12.7 mm Hg (P=0.0072, compared
with all other groups). The data showed evidence of
significant interaction between physician intervention and
patient intervention (P=0.03), suggesting that the effect of
patient intervention was enhanced by coincident exposure
to physician intervention (or vice versa).
Discussion
The results at 6 months suggest that physician intervention,
which as a management strategy alone did not show
significant benefit, may have enhanced the BP-lowering
effect of patient intervention. Even though physician
intervention alone showed limited BP-lowering effects
compared with patient intervention alone, this study
concluded that combined intervention may have changed
the doctor-patient interaction in such a way that the
physician was more likely to intensify antihypertensive
treatment.
Comments
Short-term success does not assure long-term benefit.
Although this study’s primary end point of SBP lowering
at 6 months demonstrated the significant BP effects from
either patient intervention or combined intervention,
Svetkey et al. [3] could not detect long-lasting significant
effects on BP at 18 months of either patient intervention
alone, physician intervention alone, or synergism of the two
interventions. In spite of this disappointing lack of long-
term effects on BP, the investigators did observe that effects
on behavior (i.e., improved dietary pattern and weight loss)
in the combined intervention group at 18 months was
comparable to those found at 6 months. This trend is
important because the decrease of SBP in the patient-
intervention group may be attributable to dietary improve-
ment and weight loss [3]. Perhaps effective maintenance of
a healthy lifestyle and weight control is the key to
extending intervention benefits beyond the 6 months.
The study-design weaknesses in the HIP study have been
suggested by Taler [6] in the editorial commentary section
of the same journal issue. One caveat concerns a develop-
ment that arose during the study: most patients already had
hypertension controlled at entry (about 60% were already at
goal). Taler suggested that the inclusion of study subjects
with BP already at goal may have lessened the motivation
for physicians or patients alike to commit to long-term
changes that are beneficial to hypertension control, which
may explain the relative lack of effects on diet and BP at
18 months. However, that same “limitation” may also be
viewed as a strength, in that inclusion of subjects already at
BP goal may allow the generalization of study conclusions
to a greater fraction of the at-risk population.
Replication is a critical validating step for any scientific
result. The HIP study indeed uncovered patterns similar to
those observed in two previous reports, the PREMIER trial
[7] and a 2006 study by Roumie et al. [8]. Even though the
other two trials had differing subject-entry criteria, all three
studies showed that physician-only intervention or educa-
150 Curr Hypertens Rep (2010) 12:149–151tion provided marginal benefit, whereas patient intervention
and education added benefit in BP lowering.
Current hypertension control rates in the United States
have been reported in two independent studies to be as low
as about 44% among hypertensive patients [9, 10] and only
64% even among treated hypertensive patients [9]. Because
effective control of BP reduces the risk of cardiovascular
events [11], there is clearly substantial room for improve-
ment in rates of successful BP control. The HIP study
highlights the promise of dual-level, comprehensive, non-
pharmacologic BP management strategies. The results of
this approach provide physicians with initial evidence-
based data upon which clinical practice improvements can
be based. The interest of the study resides not only in the
importance of the questions asked but also in the
significance of the findings on BP.
Certainly, challenges remain in identifying and imple-
menting the most useful and cost-effective strategies to
maintain adherence to positive lifestyle changes and
treatment compliance even after the initial intervention
period has concluded [12]. Other novel interventions that
Svetkey et al. [3] have studied include the use of home BP-
monitoring devices [13], once again suggesting that
combined intervention (home BP monitoring plus tailored
behavioral telephone intervention) may be more effective
than usual care alone [13]. In conclusion, effective BP
management remains an elusive objective for health care
providers to achieve. As Svetkey et al. [3] stated, “Future
development and testing of both patient and provider
interventions should be a high priority” in pursuit of the
ultimate goal of successful hypertension treatment.
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